Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study

Abhijit Paul, Harshith B Kadnur, Animesh Ray, Samrat Chatterjee, Naveet Wig
doi: https://doi.org/10.1101/2021.01.22.21250328

Article Information

doi 
https://doi.org/10.1101/2021.01.22.21250328
History 
  • January 29, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Abhijit Paula,
  2. Harshith B Kadnurb,
  3. Animesh Ray*,b,
  4. Samrat Chatterjeea and
  5. Naveet Wigb
  1. aComplex analysis group, Translational Health Science and Technology Institute (THSTI), Faridabad-121001, Haryana, India
  2. bDepartment of Medicine, All India Institute of Medical Science, New Delhi, India
  1. ↵*Corresponding author: Dr Animesh Ray, Assistant Professor, Department of Medicine, All India Institute of Medical Science, New Delhi, India-110029 Email- doctoranimeshray{at}gmail.com
Back to top
Posted January 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
Abhijit Paul, Harshith B Kadnur, Animesh Ray, Samrat Chatterjee, Naveet Wig
medRxiv 2021.01.22.21250328; doi: https://doi.org/10.1101/2021.01.22.21250328
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area